ZIVO: ZIVO Bioscience, Inc. Stock

by  •  • Comments Off on ZIVO: ZIVO Bioscience, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 28.51
Enterprise Value ($M) 28.70
Book Value ($M) -2.08
Book Value / Share -0.55
Price / Book -13.69
NCAV ($M) -2.14
NCAV / Share -0.56
Price / NCAV -13.31

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -24.64
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.17
Current Ratio 0.17

Balance Sheet (mrq) ($M)
Current Assets 0.44
Assets 0.50
Liabilities 2.58
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
06-12 13D Marchiando Keith 9.40
06-12 13D Payne John Bernard 8.50
06-12 13D Cornell Alison A 7.40
06-07 13D/A Maggiore Christopher D. 14.00 29.06
04-09 13D/A Strome Mezzanine Fund, Lp 9.10 -53.33

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K (Mark One)

(click for more detail)

Similar Companies
VREOF – Vireo Growth Inc. WCUI – Wellness Center USA, Inc.
XSNX – NovAccess Global Inc.


Financial data and stock pages provided by
Fintel.io